|
| |
Celgene CorporationCelgene is a pharmaceutical company with a major focus on the discovery, development and commercialization of small molecules for cancer and immunological diseases.Celgene's medical research and development team is working to extend the boundaries in the areas of small molecule immunotherapeutic and biocatalytic chiral chemistry by developing both new pharmaceuticals and chirally pure versions of existing drugs. Celgene's agrochemical unit, Celgro, is dedicated to the development of chirally pure crop protection agents.
Our goal is to provide hope and ease suffering through the discovery and development of products for therapies for patients with severe and difficult to treat diseases.
| Contact Details: |
| 86 Morris Avenue |
| Summit |
| NJ |
| 07901 |
| United States of America |
| Tel: | 1-908-673-9000 |
| Fax: | 908 271 4184 |
| Email: | |
| WWW: | www.celgene.com/
|
|
Loading...
|
Recent Publications by Celgene Corporation: |  |
Pomalidomide and lenalidomide induce p21 WAF-1 expression in both lymphoma and multiple myeloma through a LSD1-mediated epigenetic mechanism.
Lenalidomide and pomalidomide have both been evaluated clinically for... | 8th October, 2009
| Celgene, San Diego, California 92121, USA.
| Cancer Res. 2009 Sep 15;69(18):7347-56. Epub 2009 Sep 8.
DOI Direct Link |
Lenalidomide Oral Monotherapy Produces Durable Responses in Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma.
PURPOSE: Lenalidomide is a novel immunomodulatory agent with... | 7th October, 2009
| Mayo Clinic, Rochester, MN; Montefiore Medical Center-North Division, and
| J Clin Oncol. 2009 Oct 5.
DOI Direct Link |
Multicenter, Phase I, Dose-Escalation Trial of Lenalidomide Plus Bortezomib for Relapsed and Relapsed/Refractory Multiple Myeloma.
PURPOSE: Lenalidomide and bortezomib are active in relapsed and... | 30th September, 2009
| Department of Medical Oncology, Dana-Farber Cancer Institute; and Israel
| J Clin Oncol. 2009 Sep 28.
DOI Direct Link |
Determination of the residual ethanol in hydroalcoholic sealed hard gelatin capsules by static headspace gas chromatography with immiscible binary solvents.
Static headspace gas chromatography (HS-GC) with immiscible binary... | 11th September, 2009
| Analytical Research and Development, Celgene Corporation, Summit, NJ
| J Chromatogr A. 2009 Apr 10;1216(15):3328-36. Epub 2009 Feb 21.
DOI Direct Link |
Thalidomide chemotherapy-induced peripheral neuropathy: actual status and new perspectives with thalidomide analogues derivatives.
IMiDs compounds are a class of analogues of thalidomide, with greater... | 20th August, 2009
| Medical Department, Celgene S.r.l., Corso Garibaldi 86 - 20121 Milano,
| Mini Rev Med Chem. 2009 Jun;9(7):760-8.
|
→View more Celgene Corporation research publications. |
Press Releases on Celgene Corporation:
|
 |
| Alexandria Real Estate Equities, Inc. Provides Update |
29th October, 2009 |
Alexandria Real Estate Equities, Inc. |
PASADENA, Calif., Oct. 29 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), Landlord of Choice to the Life Science Industry®, today provided an update highlighting recent
|
| Updated NCCN Guidelines for AML Include Risk Stratification to Assist in Treatment Selection |
19th October, 2009 |
National Comprehensive Cancer Network |
The National Comprehensive Cancer Network (NCCN) recently updated the NCCN Guidelines for Acute Myeloid Leukemia (AML), the most common acute leukemia affecting adults. Noteworthy updates include the
|
| Prix Galien USA Announces 2009 Final Candidates |
7th August, 2009 |
Prix Galien USA |
-- Wyeth, TORISEL(R)
Best Biotechnology Product:
-- Amgen, Nplate(R)
-- GlaxoSmithKline, PROMACTA(R) and Tykerb(R)
-- Schering-Plough, PEGINTRON(R)
-- Tibotec, INTELENCE(TM
|
| New Report Just Published: World Multiple Myeloma Therapeutics Market Report |
7th July, 2009 |
Reportlinker |
NEW YORK, July 7 /PRNewswire/ -- Reportlinker.com just added a new market research report to its catalogue.
World Multiple Myeloma Therapeutics Market
http://www.reportlinker.com/p0119496/World
|
| Industry Partners Step Up To Help Blood Cancer Patients |
11th June, 2009 |
The Leukemia & Lymphoma Society |
WHITE PLAINS, N.Y., June 11 /PRNewswire/ -- Responding to an appeal for help, two companies, Celgene Corporation and Millennium: The Takeda Oncology Company, have stepped up to help blood cancer
|
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 20 individuals from Celgene Corporation using this service.  Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 3424 times since April 2007, the link to the organisation's website has been followed 369 times Recent Search Terms used to find this page: celgane | celgene pharmaceuticals | celgene pharmaceuticals | celgene pharmaceuticals | celgene pharmaceuticals co-promote | Celgene September 2009 | celgene | celgene pharmaceutical | celgane | release september 6 2009 pharma | . Search for more companies in Summit Search for more companies in NJ This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Celgene Corporation |
